A study in 2005 demonstrated that the chromosome 21 genomic fusion event TMPRSS2-ERG, between the transmembrane protease serine 2 TMPRSS2 and the members of the ETS (erythroblast transformation-specific) transcription factor family ERG, is common in prostate cancer [13]. This evidence concerns the gene ERG and prostate carcinoma.